Clinical trial
Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection - a Multi-center Randomized Controlled Trial
NCT03779087 is registered in ClinicalTrials.gov with Ping-I (William) Hsu, M.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacies of Two Bismuth Quadruple Therapies in the Second-line Treatment of H Pylori Infection - a Multi-center Randomized Controlled Trial
- Lead sponsor
- Ping-I (William) Hsu, M.D.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 11, 2018
- Completion date
- June 30, 2020
- Enrollment
- 112 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
helicobacter pylori infection